4 European Projects Found
Searched on 125080 European Projects
FINISHED
Secretariat of the technology platform for the electricity networks of the future (SmartGrids-ETPS-III)
Start date: Oct 1, 2012, End date: Jun 30, 2016,
The European Technology Platform for Electricity Networks of the Future, also called SmartGrids ETP, began its work in 2005. It aims at fostering cooperation of major stakeholders in these fields through the design, update and implementation of a Strategic Research Agenda. In this context the Platform secretariat seeks to create strong links among stakeholders and R&D and Demonstration initiatives ...
Read Project
4
Partners Participants
FINISHED
Planning for energy efficient cities (PLEEC)
Start date: Apr 1, 2013, End date: Mar 31, 2016,
Today climate change causes serious problems to the societies worldwide and Europe starts to feel its consequences. At the same time European community is facing economical problems. One of the main producers of greenhouse gases is the non sustainable energy production and use. Therefore there is an urgent need to reduce energy use in most cost effective way.PLEEC will gather cities with innovativ ...
Read Project
18
Partners Participants
FINISHED
ICT services for Electric Vehicle Enhancing the User experience (ICT 4 EVEU)
Start date: Jan 1, 2012, End date: Mar 31, 2015,
ICT 4 EVEU is a project born with the aim of deploying an innovative set of ICT services for electric vehicle (EV) in different and complementary pilots across Europe. The scope of the ICT services is the integration of different management systems operating on the existing EV infrastructures in the cities where the pilots will be run, so that related services are deployed making use of these inte ...
Read Project
17
Partners Participants
FINISHED
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis (REGENER-AR)
Start date: Jan 1, 2012, End date: Dec 31, 2014,
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide with little variation of the prevalence among countries.The current pharmacological management of RA involves early intervention with synthetic disease modifying anti-rheumatic drugs (DMARDs) either singly or in com ...
Read Project
